BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15784771)

  • 1. Sonographic depiction of intratumoral vascularity with 2- and 3-dimensional color Doppler techniques.
    Fleischer AC; Milam MR; Crispens MA; Shappell HW
    J Ultrasound Med; 2005 Apr; 24(4):533-7. PubMed ID: 15784771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis.
    Yang WT; Tse GM; Lam PK; Metreweli C; Chang J
    J Ultrasound Med; 2002 Nov; 21(11):1227-35. PubMed ID: 12418764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional quantification of tumor vascularity as a tertiary test after B-mode and power Doppler evaluation for detection of ovarian cancer.
    Guerriero S; Ajossa S; Piras S; Gerada M; Floris S; Garau N; Minerba L; Paoletti AM; Melis GB
    J Ultrasound Med; 2007 Oct; 26(10):1271-8. PubMed ID: 17901131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantified color Doppler sonography of tumor vascularity in an animal model.
    Fleischer AC; Wojcicki WE; Donnelly EF; Pickens DR; Thirsk G; Thurman GB; Hellerqvist CG
    J Ultrasound Med; 1999 Aug; 18(8):547-51. PubMed ID: 10447080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses.
    Kupesic S; Kurjak A
    Obstet Gynecol; 2000 Sep; 96(3):452-8. PubMed ID: 10960641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic depiction of ovarian vascularity and flow: current improvements and future applications.
    Fleischer AC; Brader KR
    J Ultrasound Med; 2001 Mar; 20(3):241-50. PubMed ID: 11270528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonographic quantification of ovarian tumor vascularity.
    Wilson WD; Valet AS; Andreotti RF; Green-Jarvis B; Lyshchik A; Fleischer AC
    J Ultrasound Med; 2006 Dec; 25(12):1577-81. PubMed ID: 17121953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional color Doppler sonography and uterine artery arteriography of fibroids: assessment of changes in vascularity before and after embolization.
    Muniz CJ; Fleischer AC; Donnelly EF; Mazer MJ
    J Ultrasound Med; 2002 Feb; 21(2):129-33. PubMed ID: 11833868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most Thyroid Cancers Detected by Sonography Lack Intranodular Vascularity on Color Doppler Imaging: Review of the Literature and Sonographic-Pathologic Correlations for 698 Thyroid Neoplasms.
    Yang GCH; Fried KO
    J Ultrasound Med; 2017 Jan; 36(1):89-94. PubMed ID: 27943373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do contrast media add to three-dimensional power Doppler evaluation of adnexal masses?
    Sparac V; Kupesić S; Kurjak A
    Croat Med J; 2000 Sep; 41(3):257-61. PubMed ID: 10962043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of stage I ovarian cancer by three-dimensional sonography and power Doppler.
    Kurjak A; Kupesic S; Sparac V; Prka M; Bekavac I
    Gynecol Oncol; 2003 Aug; 90(2):258-64. PubMed ID: 12893185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study.
    Testa AC; Ajossa S; Ferrandina G; Fruscella E; Ludovisi M; Malaggese M; Scambia G; Melis GB; Guerriero S
    Ultrasound Obstet Gynecol; 2005 Jul; 26(1):67-72. PubMed ID: 15971296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler sonography of benign and malignant ovarian masses.
    Fleischer AC; Rodgers WH; Kepple DM; Williams LL; Jones HW; Gross PR
    Radiographics; 1992 Sep; 12(5):879-85. PubMed ID: 1529130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional power Doppler vascular sonographic sampling for predicting ovarian cancer in cystic-solid and solid vascularized masses.
    Alcázar JL; Rodriguez D
    J Ultrasound Med; 2009 Mar; 28(3):275-81. PubMed ID: 19244062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models.
    Marret H; Ecochard R; Giraudeau B; Golfier F; Raudrant D; Lansac J
    Ultrasound Obstet Gynecol; 2002 Dec; 20(6):597-604. PubMed ID: 12493050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
    Fleischer AC; Lyshchik A; Andreotti RF; Hwang M; Jones HW; Fishman DA
    AJR Am J Roentgenol; 2010 Feb; 194(2):343-8. PubMed ID: 20093594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications.
    Fleischer AC
    J Ultrasound Med; 2000 Jan; 19(1):55-61. PubMed ID: 10625191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three dimensional ultrasound and power doppler in assessment of uterine and ovarian angiogenesis: a prospective study.
    Kurjak A; Kupesić S
    Croat Med J; 1999 Sep; 40(3):413-20. PubMed ID: 10411971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.